Yan-Feng Tang Selected Research

Pulmonary Heart Disease (Cor Pulmonale)

1/2024

Platelet-to-Lymphocyte Ratio (PLR), Neutrophil-to-Lymphocyte Ratio (NLR), Monocyte-to-Lymphocyte Ratio (MLR), and Eosinophil-to-Lymphocyte Ratio (ELR) as Biomarkers in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yan-Feng Tang Research Topics

Disease

1	Chronic Obstructive Pulmonary Disease (COPD) 01/2024
1	Pneumonia (Pneumonitis) 01/2024
1	Pulmonary Heart Disease (Cor Pulmonale) 01/2024
1	Vasculitis (Vasculitides) 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2022
1	Surgical Wound 05/2018
1	Infections 05/2018
1	Multiple Fractures 05/2018
1	Neoplasms (Cancer) 08/2009

Drug/Important Bio-Agent (IBA)

1	Uric Acid (Urate)IBA 01/2024
1	AlbuminsIBA 01/2024
1	Biomarkers (Surrogate Marker)IBA 01/2024
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022
1	MicroRNAs (MicroRNA)IBA 08/2009

Therapy/Procedure

1	Operative Time 05/2018
1	Fracture Fixation 05/2018
1	Intramedullary Fracture Fixation 05/2018